TDAC · Forms 3, 4, 5
Insider trades at Translational Development Acquisition Corp.
No open-market insider buys or sells at Translational Development Acquisition Corp. in the last 90 days; 8 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Translational Development Acquisition Corp. (TDAC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Translational Development Acquisition Corp. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael B Hoffman | Chairman and CEO | Options or other derivatives | Form 4 | ||||
| Christopher Kenneth Jarratt | Director | Became an insider (Form 3) | Form 3 | ||||
| Curtis T Keith | Director | Became an insider (Form 3) | Form 3 | ||||
| TDAC Partners LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| E Premkumar Reddy | Director | Became an insider (Form 3) | Form 3 | ||||
| Matthew Kestenbaum | Director | Became an insider (Form 3) | Form 3 | ||||
| Michael B Hoffman | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Avanindra Das | Chief Financial Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.